DK1427812T3 - Produktion af dyrkede, humane mastceller og basofiler til höj-kapacitets drug discovery af små molekyler - Google Patents

Produktion af dyrkede, humane mastceller og basofiler til höj-kapacitets drug discovery af små molekyler

Info

Publication number
DK1427812T3
DK1427812T3 DK02763580T DK02763580T DK1427812T3 DK 1427812 T3 DK1427812 T3 DK 1427812T3 DK 02763580 T DK02763580 T DK 02763580T DK 02763580 T DK02763580 T DK 02763580T DK 1427812 T3 DK1427812 T3 DK 1427812T3
Authority
DK
Denmark
Prior art keywords
cells
mast cells
screening
methods
basophils
Prior art date
Application number
DK02763580T
Other languages
English (en)
Inventor
Alexander B Rossi
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1427812T3 publication Critical patent/DK1427812T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0642—Granulocytes, e.g. basopils, eosinophils, neutrophils, mast cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK02763580T 2001-08-31 2002-08-29 Produktion af dyrkede, humane mastceller og basofiler til höj-kapacitets drug discovery af små molekyler DK1427812T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31672301P 2001-08-31 2001-08-31
US10/053,355 US7070996B2 (en) 2001-08-31 2001-11-08 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
PCT/US2002/027628 WO2003020896A2 (en) 2001-08-31 2002-08-29 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery

Publications (1)

Publication Number Publication Date
DK1427812T3 true DK1427812T3 (da) 2009-03-16

Family

ID=26731760

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02763580T DK1427812T3 (da) 2001-08-31 2002-08-29 Produktion af dyrkede, humane mastceller og basofiler til höj-kapacitets drug discovery af små molekyler

Country Status (8)

Country Link
US (2) US7070996B2 (da)
EP (1) EP1427812B1 (da)
JP (1) JP4388372B2 (da)
AT (1) ATE414762T1 (da)
AU (1) AU2002327583A1 (da)
DE (1) DE60229960D1 (da)
DK (1) DK1427812T3 (da)
WO (1) WO2003020896A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029697B2 (en) 2001-02-14 2006-04-18 Northwestern University Controlled surface-associated delivery of genes and oligonucleotides
TWI329105B (en) * 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
WO2004015389A2 (en) * 2002-08-09 2004-02-19 Rigel Pharmaceuticals, Inc. Methods of identifying compouds that modulate igg mediated mast cell activation
NZ545270A (en) * 2003-07-30 2010-04-30 Rigel Pharmaceuticals Inc 2,4-Pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
JP2007536936A (ja) 2004-05-14 2007-12-20 ベクトン・ディキンソン・アンド・カンパニー 幹細胞集団および使用方法
WO2006004865A1 (en) * 2004-06-29 2006-01-12 Rigel Pharmaceuticals, Inc. 2-substituted quinoline compounds and their uses as inhibitors of the ige receptor signaling cascade
CN1993460A (zh) * 2004-07-12 2007-07-04 索林集团意大利有限公司 用于培养人细胞的装置和方法
JP4653842B2 (ja) 2006-02-17 2011-03-16 ライジェル ファーマシューティカルズ， インコーポレイテッド 自己免疫疾患を治療または予防するための２，４−ピリミジンジアミン化合物
US20100015615A1 (en) * 2008-04-30 2010-01-21 Sloan-Kettering Institute For Cancer Research Identification and Isolation of Adult Stem Cells and Related Methods of Use
WO2010105215A2 (en) * 2009-03-12 2010-09-16 University Of South Florida Human mast cell line and uses thereof
EP2475767B1 (en) * 2009-09-08 2017-04-19 Kyoto University Method for producing mast cells from pluripotent stem cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2052035A (en) * 1932-03-21 1936-08-25 Thomas R Potter Combination game board and accessories
US4559310A (en) 1983-05-20 1985-12-17 Dana Farber Cancer Institute Assay methods and systems utilizing mast cell clones
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US6190655B1 (en) 1993-12-03 2001-02-20 Immunex Corporation Methods of using Flt-3 ligand for exogenous gene transfer
FR2728584A1 (fr) 1994-12-22 1996-06-28 Centre Nat Rech Scient Procede de transfert de gene dans des cellules activees a partir d'un etat de repos
WO2001000788A2 (en) 1999-06-25 2001-01-04 Northwestern University Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells

Also Published As

Publication number Publication date
US7070996B2 (en) 2006-07-04
DE60229960D1 (de) 2009-01-02
EP1427812B1 (en) 2008-11-19
JP4388372B2 (ja) 2009-12-24
WO2003020896A9 (en) 2003-12-18
EP1427812A4 (en) 2005-04-27
WO2003020896A2 (en) 2003-03-13
ATE414762T1 (de) 2008-12-15
AU2002327583A1 (en) 2003-03-18
US20030077824A1 (en) 2003-04-24
EP1427812A2 (en) 2004-06-16
WO2003020896A3 (en) 2003-10-30
US20070015280A1 (en) 2007-01-18
JP2005501552A (ja) 2005-01-20

Similar Documents

Publication Publication Date Title
DK1427812T3 (da) Produktion af dyrkede, humane mastceller og basofiler til höj-kapacitets drug discovery af små molekyler
Griffiths et al. The arguments for pre-existing early and late endosomes.
GB0312481D0 (en) Antibodies
SG170068A1 (en) Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
IL196893A (en) Cell or cell line of vertebrate-containing amino acids trna synthase
EP1483281A4 (en) METHOD FOR THE PRODUCTION OF INTERFERING RNA MOLECULES IN MAMMALIAN CELLS AND THERAPEUTIC APPLICATIONS OF SUCH MOLECULES
NZ569543A (en) Means and methods for influencing the stability of antibody producing cells
CY1113321T1 (el) Παραγωγη ενος πληθυσμου κυτταρων in vitro χρησιμοποιωντας κυτταρα τροφοδοτη
DE69632949D1 (de) Die aktivierung von rezeptoren durch gas6
PE20090731A1 (es) Metodos de produccion de proteinas basados en medios de cultivos celulares que comprenden compuestos anti-senescencia
WO2002041906A3 (en) Methods and apparatus for producing gender enriched sperm
AR055223A1 (es) Caracterizacion y compensacion de electrodos del ecg
CY1112394T1 (el) Παραγωγη fgf18 σε προκαρυωτικους ξενιστες
BR0212545A (pt) Composições e métodos para preparar células dendrìticas monocìticas e células t para resposta de th-1
MXPA02012324A (es) Metodos y composiciones para la sacarificacion y fermentacion simultaneas.
NO20025151L (no) Nye forbindelser
DK1321477T3 (da) Fremgangsmåde til frembringelsen af genetisk modificerede vertebrate precursor-lymfocytter og anvendelse deraf til fremstillingen af heterologe bindende proteiner
GB2387847B (en) Method for producing monoclonal antibodies
AU2003288621A8 (en) Rna bioassay
WO2004072262A3 (en) Cultured cd14+ antigen presenting cells
WO2022164807A3 (en) Genetically modified hepatocyte populations
WO2005054447A3 (en) Müller stem cells
WO2003063783A3 (en) Multiple virus replicon culture systems
BRPI0507173A (pt) método para produzir polìmeros de polifenileno substituìdo
PT1242653E (pt) Celulas electroquimicas para electrolisador com tecnica de elementos individuais